01-07-2021 | Tranexamic Acid | Letter to the Editor
Comment on “Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial”
Published in: International Orthopaedics | Issue 7/2021
Login to get access